TXNRD1 and cancer: TXNRD1 inhibition can lead to an impairment of required antioxidant capacity particularly in cancer cells, while normal cells can survive a loss of TXNRD1 activity, it is thus not far-fetched to propose that TXNRD1 inhibition may be a potential mechanism of action for anticancer drugs [17].